PD-1/PD-L1 Inhibitors versus Chemotherapy for Previously Treated Advanced Gastroesophageal Cancer: A Meta-Analysis of Randomized Controlled Trials

<div>Meta-analysis results of overall survival (OS) between the PD-1/PD-L1 inhibitor group and chemotherapy group. (a) All patients. (b) Squamous cell carcinoma subgroup. (c) Adenocarcinoma subgroup.</div>

Journal of Oncology

fig5

Figure 5

Figure 5: PD-1/PD-L1 Inhibitors versus Chemotherapy for Previously Treated Advanced Gastroesophageal Cancer: A Meta-Analysis of Randomized Controlled Trials 

Figure 5 | PD-1/PD-L1 Inhibitors versus Chemotherapy for Previously Treated Advanced Gastroesophageal Cancer: A Meta-Analysis of Randomized Controlled Trials 